These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9670849)

  • 1. Cerebrospinal fluid thrombomodulin and sVCAM-1 in different clinical stages of multiple sclerosis patients.
    Frigerio S; Ariano C; Bernardi G; Ciusani E; Massa G; La Mantia L; Salmaggi A
    J Neuroimmunol; 1998 Jul; 87(1-2):88-93. PubMed ID: 9670849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and cerebrospinal fluid levels of soluble adhesion molecules in multiple sclerosis: predominant intrathecal release of vascular cell adhesion molecule-1.
    Droogan AG; McMillan SA; Douglas JP; Hawkins SA
    J Neuroimmunol; 1996 Feb; 64(2):185-91. PubMed ID: 8632061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration of soluble adhesion molecules (sVCAM-1, sICAM-1 and sL-selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement.
    Baraczka K; Nékám K; Pozsonyi T; Jakab L; Szongoth M; Seszták M
    Neuroimmunomodulation; 2001; 9(1):49-54. PubMed ID: 11435752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of tumor necrosis alpha and soluble vascular endothelial adhesion molecule-1 in the cerebrospinal fluid of patients with connective tissue diseases and multiple sclerosis.
    Baraczka K; Pozsonyi T; Szüts I; Ormos G; Nékám K
    Acta Microbiol Immunol Hung; 2003; 50(4):339-48. PubMed ID: 14750436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raised CSF levels of soluble adhesion molecules across the clinical spectrum of multiple sclerosis.
    McDonnell GV; McMillan SA; Douglas JP; Droogan AG; Hawkins SA
    J Neuroimmunol; 1998 May; 85(2):186-92. PubMed ID: 9630167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of soluble adhesion molecules in blood and cerebrospinal fluid with magnetic resonance imaging activity in patients with multiple sclerosis.
    Rieckmann P; Altenhofen B; Riegel A; Kallmann B; Felgenhauer K
    Mult Scler; 1998 Jun; 4(3):178-82. PubMed ID: 9762670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of increased levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) in the cerebrospinal fluid of patients with multiple sclerosis and systemic lupus erythematosus.
    Baraczka K; Pozsonyi T; Szongoth M; Nékám K; Megyeri A; Balogh Z; Jakab L
    Acta Neurol Scand; 1999 Feb; 99(2):95-9. PubMed ID: 10071167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of soluble vascular cell adhesion molecule-1 (VCAM-1) in the cerebrospinal fluid and sera of patients with multiple sclerosis and human T lymphotropic virus type-1-associated myelopathy.
    Matsuda M; Tsukada N; Miyagi K; Yanagisawa N
    J Neuroimmunol; 1995 Jun; 59(1-2):35-40. PubMed ID: 7541057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular cell adhesion molecule--a new approach to detect endothelial cell activation in MS and encephalitis in vivo.
    Mössner R; Fassbender K; Kühnen J; Schwartz A; Hennerici M
    Acta Neurol Scand; 1996; 93(2-3):118-22. PubMed ID: 8741129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity.
    Dore-Duffy P; Newman W; Balabanov R; Lisak RP; Mainolfi E; Rothlein R; Peterson M
    Ann Neurol; 1995 Jan; 37(1):55-62. PubMed ID: 7529475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between biochemical parameters of cerebrospinal fluid and the course of multiple sclerosis].
    Smagina IV; El'chaninova SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(10 Pt 2):43-6. PubMed ID: 24300814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble HLA class I and class II molecule levels in serum and cerebrospinal fluid of multiple sclerosis patients.
    Filaci G; Contini P; Brenci S; Gazzola P; Lanza L; Scudeletti M; Indiveri F; Mancardi GL; Puppo F
    Hum Immunol; 1997 Apr; 54(1):54-62. PubMed ID: 9154458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging.
    Giovannoni G; Lai M; Thorpe J; Kidd D; Chamoun V; Thompson AJ; Miller DH; Feldmann M; Thompson EJ
    Neurology; 1997 Jun; 48(6):1557-65. PubMed ID: 9191766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
    Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
    J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the clinical utility of cerebrospinal fluid (CSF) indices of inflammatory markers in multiple sclerosis.
    McMillan SA; McDonnell GV; Douglas JP; Hawkins SA
    Acta Neurol Scand; 2000 Apr; 101(4):239-43. PubMed ID: 10770519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin α-4-transduced outside-in signalling.
    Haarmann A; Nowak E; Deiß A; van der Pol S; Monoranu CM; Kooij G; Müller N; van der Valk P; Stoll G; de Vries HE; Berberich-Siebelt F; Buttmann M
    Acta Neuropathol; 2015 May; 129(5):639-52. PubMed ID: 25814153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of soluble NCAM in multiple sclerosis.
    Ziliotto N; Zivadinov R; Jakimovski D; Baroni M; Tisato V; Secchiero P; Bergsland N; Ramasamy DP; Weinstock-Guttman B; Bernardi F; Ramanathan M; Marchetti G
    J Neurol Sci; 2019 Jan; 396():36-41. PubMed ID: 30412901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
    Chowdhury SA; Lin J; Sadiq SA
    Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface bound and soluble adhesion molecules in CSF and blood in multiple sclerosis: correlation with MRI-measures of subclinical disease severity and activity.
    Kraus J; Engelhardt B; Chatzimanolis N; Bauer R; Tofighi J; Kuehne BS; Laske C; Stolz E; Frielinghaus P; Schaefer C; Blaes F; Traupe H; Kaps M; Oschmann P
    J Neuroimmunol; 2002 Jan; 122(1-2):175-85. PubMed ID: 11777557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.